New York Blood Center

New York Blood Center is one of the largest independent, community-based nonprofit blood centers in the United States, established in 1964. It operates laboratories that conduct patient antibody testing, blood typing, and antigen analysis, as well as HLA testing for bone marrow and cord blood donors, platelet recipients, and investigations related to transfusion-related acute lung injury (TRALI). Each year, New York Blood Center supplies approximately one million blood products to hospitals across the Northeast, playing a crucial role in saving the lives of patients undergoing cancer treatments, surgeries, or those suffering from conditions such as AIDS, sickle cell anemia, and hemophilia. Its mission is to ensure a safe and reliable blood supply through collaboration with community and corporate partners, along with the support of blood donors and volunteers.

Karina Yazdanbakhsh

Executive Director

1 past transactions

KaloCyte

Seed Round in 2022
KaloCyte Inc., established in 2016 and based in Baltimore, Maryland, is a pre-clinical stage healthcare biotechnology company focused on developing innovative solutions for life-threatening blood loss scenarios. The company's flagship product, ErythroMer, is an artificial red blood cell substitute designed to be dried and bio-inspired, intended for use when stored red blood cells are unavailable or undesirable. This product aims to address critical gaps in trauma care services by providing a demonstrated proof of concept for treating hemorrhage situations effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.